Chandigarh, 16 January 2026: India has one of the world’s highest total burden of Parkinson’s Disease, with a substantial number of patients experiencing onset of motor symptoms in their prime working years, yet not many know the promise of Deep Brain Stimulation (DBS). This cutting-edge neurostimulation procedure, offered at Medanta– The Medicity, Gurugram by Dr. Anirban Deep Banerjee, is helping hundreds of patients with advanced neurological disorders such as Punjab resident Mr. Naunihal Singh, in his 80s, who was at the brink of becoming disabled. 

Medanta, one of the largest private multi-specialty tertiary and quaternary care providers in the country, is an internationally known destination for Deep Brain Stimulation (DBS) therapy, also known as ‘Brain-Pacemaker surgery’. This comprehensive treatment employs advanced imaging techniques for precise brain targeting and utilizes state-of-the-art innovations such as directional leads for multi-dimensional neuromodulation and real-time brain-sensing biomarker feedback for symptom-responsive stimulation.

Dr. Anirban Deep Banerjee, Director-Neurosurgery at the Institute of Neurosciences, Medanta, stated, “Neurological conditions are now one of the leading causes of disability worldwide, with the global burden of illness and disability rising substantially over last few decades. In India, they account for about 10% of the total disease burden. While we have recognised, effective, advanced treatments like DBS to help transform lives, as in the case of Mr. Singh, access remains a significant challenge. 

He added, “DBS or Brain Pacemaker Surgery is a transformative therapy wherein electrodes are implanted in specific affected areas of the brain to regulate abnormal signals, restoring motor function, and greatly enhancing quality of life. It is known to bring relief to advanced-stage symptoms of Parkinson’s Disease, dystonia, epilepsy (adult onset), essential tremor, and obsessive-compulsive disorder (OCD).”

Dr. Banerjee has performed well over 300 DBS procedures over the past decade-and-a-half with remarkable success rates, reinforcing his reputation as one of the most trusted neurosurgeons for DBS surgery in this part of the world. At Medanta, DBS also includes patient/condition-specific advanced AI-guided brain area targeting and remote programming capabilities. These features of the program will be especially useful for patients in Bhopal, who can benefit continuous care without the need for frequent travel to metro cities for this advanced procedure.